0000899243-22-014880.txt : 20220415
0000899243-22-014880.hdr.sgml : 20220415
20220415161548
ACCESSION NUMBER: 0000899243-22-014880
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20220415
DATE AS OF CHANGE: 20220415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ridloff Elena
CENTRAL INDEX KEY: 0001772518
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 22830190
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-06-16
2021-06-17
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001772518
Ridloff Elena
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
1
0
0
0
Stock Option (Right to Buy)
49.10
2021-06-16
4
A
0
10459
0.00
A
2031-06-15
Common Stock
10459
10459
D
The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.
This Amended Form 4 restates the original Form 4 in its entirety.
/s/ Bruce Jacobs, as Attorney-in-Fact
2022-04-15